Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 06, 2019

SELL
$16.27 - $20.51 $325,400 - $410,200
-20,000 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$12.61 - $22.33 $252,200 - $446,599
20,000 New
20,000 $15,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $185M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Mariner Investment Group LLC Portfolio

Follow Mariner Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner Investment Group LLC with notifications on news.